Best method disclosure for divisional patent applications
Australia’s Full Federal Court, in The NOCO Company v Brown and Watson International Pty Ltd [2026] FCAFC 44, has confirmed that applicants for divisional patent applications have an obligation to disclose the best method known to them at the filing date of the divisional application.
Design Registration Considerations for Kits of Components
Many of our clients make use of the Australian Designs system to protect the unique appearance of their products.
Claude leak: A cautionary tale for industry
The tale of Anthropic and the leak of the source code for its leading AI coding
assistant Clause should be a cautionary tale for those in the software space.
Trade Marks in FemTech: Building Brand Trust in Women’s Health
Trade marks play a key role in protecting that brand and securing a stronger market position as new products and services enter the market.
High Court listens to local designer, Katie Perry’s roar…
The High Court has today allowed Australian fashion designer Katie Jane Taylor (born Katie Jane Perry)’s appeal from the Full Court of the Federal Court of Australia in relation to her trade mark registration KATIE PERRY.
Otsuka Update: Special Leave Filed and IP Australia Refines PTE Processing Approach
The patentee has filed a special leave application to the High Court of Australia seeking to appeal the Full Court’s decision in Otsuka Pharmaceutical Co., Ltd v Sun Pharma ANZ Pty Ltd.
Has the balance shifted? Federal Court grants first preliminary injunctions to pharmaceutical patentees since 2018
Two recent decisions of the Federal Court, AstraZeneca AB v Pharmacor Pty Ltd [2026] FCA 88 and Janssen Pharmaceutica NV v Juno Pharmaceuticals Pty Ltd [2025] FCA 1538 suggest the tide may be turning back to originators seeking preliminary injunctions (PIs) to restrain generic market entry.
Why 2026 Will Be Big for Women’s Health Innovation
2026 is shaping up as a pivotal year for women’s health innovation, not because of any single technological breakthrough, but because the broader environment is changing.
High Court refuses special leave to the Commissioner of Patents for patentability of computer‑implemented inventions in Aristocrat ’25
Today, the High Court of Australia has dismissed an application for special leave to appeal from Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2025] FCAFC 131.
Being a Sole Director Can be Risk
An innovation patent owned by Southern Cross was found to be invalid in the decision Southern Cross Industrial Group Oty Ltd v Mickala Lighting Towers Pty Ltd and Damien Englebrecht [2025] FCA 1363.